High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.
Stroot IAS, Bart J, Hollema H, Wagner MM, Yigit R, van Doorn HC, de Hullu JA, Gaarenstroom KN, van Beurden M, van Lonkhuijzen LRCW, Slangen BFM, Zweemer RP, Gómez Garcia EB, Ausems MGEM, Komdeur FL, van Asperen CJ, Adank MA, Wevers MR, Hooning MJ; HEBON Investigators; Mourits MJE, de Bock GH.
Stroot IAS, et al. Among authors: van doorn hc.
J Natl Cancer Inst. 2024 Nov 23:djae300. doi: 10.1093/jnci/djae300. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 39579093